Corcept Therapeutics (CORT) Reports Q4 EPS of $0.77
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $86.95 -1.07%
Revenue Growth %: +12.1%
Financial Fact:
Research and development: 7.05M
Today's EPS Names:
DTGI, CRMT, STZ, More
Revenue Growth %: +12.1%
Financial Fact:
Research and development: 7.05M
Today's EPS Names:
DTGI, CRMT, STZ, More
Join SI Premium – FREE
Corcept Therapeutics (NASDAQ: CORT) reported Q4 EPS of $0.77, versus $0.04 reported last year. Revenue for the quarter came in at $53.3 million, versus $23.8 million reported last year.
GUIDANCE:
Corcept Therapeutics sees FY2018 revenue of $275-300 million.
For earnings history and earnings-related data on Corcept Therapeutics (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Constellation Brands (STZ) Tops Q1 EPS by 18c
- NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
- Oppenheimer turns cautious on major U.S. banks, favors alternative asset managers
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
